Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study-Reference-Cited by-同舟云学术

Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study

Published:2016-06-16 Issue:10 Volume:36 Page:849-856
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Barillà Francesco,Pannarale Giuseppe,Torromeo Concetta,Paravati Vincenzo,Acconcia Maria Cristina,Tanzilli Gaetano,Mangieri Enrico,Dominici Tania,Martino Francesco,Pannitteri Gaetano,Gaudio Carlo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0424-9.pdf

Reference17 articles.

1. Indolfi C, Ross J Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion–contraction matching. Prog Cardiovasc Dis. 1993;36:61–74.

2. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A subgroup analysis of a randomised controlled trial. Lancet. 2008;372:817–21.

3. Lechat P, Escolano S, Golmard JL, Lardoux H, Witchitz S, Henneman JA, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation. 1997;96:2197–205.

4. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation. 2001;103:1428–33.

5. Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, Di LA, Komajda M, et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: Results from the COMET trial. Eur Heart J. 2005;26:2259–68.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivabradine Approved and Other Uses in Clinical Practice: A Systematic Review;Journal of Cardiovascular Pharmacology;2024-09

2. Predictors of short-term mortality in cardiogenic shock: insights from an Egyptian multicenter registry;The Egyptian Heart Journal;2024-07-26

3. Effect of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study;Heliyon;2024-07

4. Ivabradine in Cardiogenic Shock;Journal of Cardiac Failure;2024-06

5. Ivabradine in Septic Shock: A Narrative Review;Journal of Clinical Medicine;2024-04-18